Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
09/02/2009 | CN101519421A Method for preparing high-purity demethylzelasteral |
09/02/2009 | CN101519402A Thiochromone compound, synthetic method and application thereof in preparing antifungal medicaments |
09/02/2009 | CN101519375A Antifungal pyrazoline-substituting compound and preparation method and application thereof |
09/02/2009 | CN101519368A Small molecule entry inhibitors |
09/02/2009 | CN101519361A Preparation process of lavo-ofloxacin and ofloxacin |
09/02/2009 | CN101518649A Compound preparation for treating ophthalmic infection and inflammation |
09/02/2009 | CN101518648A Soluble receptor BR43x2 and methods of using |
09/02/2009 | CN101518647A Human papilloma virus preventative vaccine, construction method and application |
09/02/2009 | CN101518644A Application of Ang-2 and genes thereof in pharmacy |
09/02/2009 | CN101518628A Medicament for treating AIDS and preparation method |
09/02/2009 | CN101518610A Orthopedic persistent ailment treating medicament and preparation method thereof |
09/02/2009 | CN101518608A Anti-candidiasis albrican cream and preparation method thereof |
09/02/2009 | CN101518602A Anti-herpes zoster traditional Chinese medical composition and preparation method thereof |
09/02/2009 | CN101518600A Chinese medicinal composition for treating bacterial or fungal dermatosis and preparation method thereof |
09/02/2009 | CN101518598A Tea oral tablet and preparation method thereof |
09/02/2009 | CN101518592A Granule used for treating cold due to wind-heat and preparation method thereof |
09/02/2009 | CN101518585A Holding prescription for treating influenza |
09/02/2009 | CN101518578A Powder for curing dermatophytosis and preparation method thereof |
09/02/2009 | CN101518574A Anti-human papilloma virus (anti-HPV) external effervescent tablet and preparation method and application thereof |
09/02/2009 | CN101518569A Human sterilizing liquid containing majoram oil and production method thereof |
09/02/2009 | CN101518549A Research and application of Mycobacterium extract |
09/02/2009 | CN101518545A Synthesis and surface decorating method of rare-earth nanometer compound material |
09/02/2009 | CN101518544A Quickly-effective beriberi powder |
09/02/2009 | CN101518543A Preparation method and product of lincomycin-gentamicin compound injection |
09/02/2009 | CN101518530A Stable solid composite medicament of compound penicillin |
09/02/2009 | CN101518526A Drug combination |
09/02/2009 | CN101518522A Allicin external preparation and prepration method thereof |
09/02/2009 | CN101518514A Econazole nitrate microemulsion aerosol and method for preparing same |
09/02/2009 | CN101518471A Antibiotic artificial hip joint |
09/02/2009 | CN100534991C Heterocyclic inhibitors of ERK 2 and uses thereof |
09/02/2009 | CN100534529C Ordered molecular presentation of antigens, method of preparation and use |
09/02/2009 | CN100534506C Chinese medicinal mixture for treating viral hepatitis |
09/01/2009 | US7582734 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling |
09/01/2009 | US7582730 an iron-regulated protein found in Neisseria gonorrhoeae or Neisseria meningitidis outer membranes; immunizing a host against gonococcal and meningococcal diseases, such as gonorrhea, meningitis |
09/01/2009 | US7582675 Flavonoid compound and process for producing the same |
09/01/2009 | US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
09/01/2009 | US7582659 effective against aerobic and anerobic pathogens such as multi-resistant staphylococci, streptococci and enterococci; 1-[5(R)-3-[4-[2-[(1 alpha ,5 alpha ,6 beta )-6-Cyano-3-azabicyclo[3.1.0]hexan-6-yl]pyridin-5-yl]-3-fluorophenyl]-2-oxooxazolidin-5-ylmethyl]-1,2,3-triazole; side effect reduction |
09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
09/01/2009 | US7582642 4-{9-Isopropyl-6-[(pyridin-3-ylmethyl)-amino]-9H-purin-2-ylamino}-2-methyl-hexan-3-ol;antiproliferative agents; viricides; alopecia; strokes; central nervous system diorders; neurodegenerative diseases; antidiabetic agents; mitosis; cyclin dependent kinase inhibitors; protein kinase inhibitors |
09/01/2009 | US7582641 Gyrase inhibitors and uses thereof |
09/01/2009 | US7582627 3-aminoquinazolin-2,4-dione antibacterial agents |
09/01/2009 | US7582624 Benzodiazepine derivatives and pharmaceutical compositions containing them |
09/01/2009 | US7582614 Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection |
09/01/2009 | US7582613 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
09/01/2009 | US7582604 Template-fixed peptidomimetics with antibacterial activity |
09/01/2009 | US7582603 Treatment of gastrointestinal inflammation by administering a peptide antagonist of tight junction opening that binds to the zonula occludens receptor, yet does not physiologically modulate the opening of mammalian tight junctions; celiac disease, inflammatory bowel disease |
09/01/2009 | US7582437 Adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof |
09/01/2009 | US7582301 Long-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptides |
09/01/2009 | US7582288 Methods of targeting multiple cytokines |
09/01/2009 | US7582287 Method for treating cervical cancer |
09/01/2009 | CA2467378C Cereal beta glucan compositions, methods of preparation and uses thereof |
09/01/2009 | CA2431206C Combination drugs containing anti-sepsis cycloalkene compound |
09/01/2009 | CA2420640C Combination preparations of 3-n-formyl hydroxy amino propyl phosphonic acid derivatives or 3-n-acetyl hydroxy amino propyl phosphonic acid derivatives together with special pharmaceutical active ingredients |
09/01/2009 | CA2400804C Stable emulsion compositions of cycloalkene derivatives |
09/01/2009 | CA2385867C Sustained release form comprising alpha-lipoic acid or derivatives thereof |
09/01/2009 | CA2272540C Anti-oxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
09/01/2009 | CA2210812C T-cell affecting peptides |
09/01/2009 | CA2158651C Multicomponent clostridial vaccines using saponin adjuvants |
08/27/2009 | WO2009105729A2 Immunogenic influenza composition |
08/27/2009 | WO2009105328A2 Inorganic sorbent copolymer |
08/27/2009 | WO2009105258A1 Oligomer conjugates of heteropentacyclic nucleosides |
08/27/2009 | WO2009105192A2 Use of saccharides cross-reactive with bacillus anthracis spore glycoprotein as a vaccine against anthrax |
08/27/2009 | WO2009105152A2 Virus-like particles as vaccines for paramyxovirus |
08/27/2009 | WO2009104831A1 Use of mutant hiv-1 protease or siv protease as an adjuvant |
08/27/2009 | WO2009104761A1 Anti-viral agents, anti-viral fibers and anti-viral fiber structures |
08/27/2009 | WO2009104670A1 Antimicrobial and antiviral agent and method for use thereof |
08/27/2009 | WO2009104159A1 Oxazolidinone derivatives |
08/27/2009 | WO2009104045A1 Ophthalmic gemifloxacin compositions for the treatment of ocular infections |
08/27/2009 | WO2009103821A2 Means for treating virus infections |
08/27/2009 | WO2009103493A1 Sgk1 as a therapeutic and diagnostic target for viral diseases |
08/27/2009 | WO2009103319A2 Proteins ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis vulgaris and poststreptococcal diseases |
08/27/2009 | WO2009103312A1 Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases |
08/27/2009 | WO2009103243A1 CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS POLYMERASE PAc-PB1n COMPLEX AND USES THEREOF |
08/27/2009 | WO2009103209A1 Stable s-(-)- nadifloxacin-l-arginine composition, its preparation method and use |
08/27/2009 | WO2009103199A1 A g-csf conjugate modified by water-soluble polymer |
08/27/2009 | WO2009083663A3 Cyclic peptides comprising at least one aza-β3-aminoacyl residue and uses thereof |
08/27/2009 | WO2009076778A8 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
08/27/2009 | WO2009076200A3 Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1h-benzo[d]imidazol-2-yl)urea |
08/27/2009 | WO2009071860A3 G immunoglobulin used against anthrax toxins |
08/27/2009 | WO2009070564A3 Compositions and methods for prevention of infection in transcutaneous osseointegrated implants |
08/27/2009 | WO2009033811A3 Therapeutic uses of muroctasin and kisspeptin13 and compositions thereof |
08/27/2009 | WO2009033760A3 Use of fibronectin fragment (196-203 ) as a therapeutic agent |
08/27/2009 | WO2009033668A3 Use of a peptide as a therapeutic agent |
08/27/2009 | WO2009033667A3 Use of a peptide as a therapeutic agent |
08/27/2009 | WO2008142513A3 Phosphate-modified oligonucleotide analogs with immunostimulatory activity |
08/27/2009 | WO2008095093A3 Method of increasing cellular function and health of glutathione deficient animals |
08/27/2009 | WO2007143231A3 Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists |
08/27/2009 | US20090217392 Anti- integrin antibodies, compositions, methods and uses |
08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
08/27/2009 | US20090215982 Glycopeptide derivatives and pharmaceutical compositions containing the same |
08/27/2009 | US20090215869 Hepatitis c virus non-structural ns3/4a fusion gene |
08/27/2009 | US20090215854 Antimicrobial compositions, products and methods employing same |
08/27/2009 | US20090215819 Anti-infective and immunomodulatory compounds |
08/27/2009 | US20090215789 Cyclic hexadepsipeptides, processes for their production and their use as pharmaceuticals |
08/27/2009 | US20090215779 Oxadiazole derivatives as dgat inhibitors |
08/27/2009 | US20090215778 Alpha-substituted Arylmethyl Piperazine Pyrazolo [1,5-alpha]Pyrimidine Amide Derivatives |
08/27/2009 | US20090215762 Siloxane polymer containing tethered levofloxacin |
08/27/2009 | US20090215747 Heterocyclic compounds as inhibitors of beta-lactamases |
08/27/2009 | US20090215739 Chemical method of making a suspension, emulsion or dispersion of pyrithione particles |